Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
83 participants
INTERVENTIONAL
2015-09-30
2020-12-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The level of effectiveness of the VDLT and non-video DLT will be compared.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Powered Vascular Stapler in Video-Assisted Thoracoscopic (VAT) Lobectomies
NCT02702921
LungPoint ATV for Biopsy in Patients Undergoing Lobectomy
NCT02130115
Vapor Ablation for Localized Cancer Lesions
NCT03514329
Phase 2B Safety and Efficacy Study of VGT-309 in Subjects With Cancer in the Lung.
NCT06145048
CT-controlled Advanced Navigation Techniques for Transbronchial Pulmonary Lesion Access; Evaluation of Augmented Fluoroscopy Bronchoscopic Navigation Based Diagnostic Yield
NCT03274609
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A fiberoptic scope is a thin device that may be placed into the breathing tube in order to check that the tube is in the correct place.
Study Groups:
If you agree to take part in this study, you will be randomly assigned (as in the flip of a coin) to 1 of 2 study groups. This is done because no one knows if one study group is better, the same, or worse than the other group. You will have an equal chance of being assigned to either group.
If you are in Group 1, you will receive a non-video DLT for lung isolation before surgery. Once the doctor thinks the non-video DLT is in the correct place, its final position before surgery will be checked with an FOB.
If you are in Group 2, you will receive a VDLT for lung isolation before surgery. Once the doctor thinks the VDLT is in the correct place, its final position before surgery will be checked with the camera inside the tube. However, if the doctor thinks it is needed, an FOB may also be used to confirm that the VDLT is in the correct place.
You will sign a separate consent form that describes the risks of surgery.
Procedures:
Once the doctor thinks the VDLT or non-video DLT is in the correct place and your lung(s) can be isolated, you will have surgery as planned. At the end of surgery, the breathing tube will be removed.
If the breathing tube cannot be placed, you will not have the surgery at that time.
Length of Study:
After the surgery, your study participation will be over.
This is an investigational study. The VDLT and non-video DLT are FDA approved and commercially available. Comparing them is investigational. The study doctor can explain how the study devices are designed to work.
Up to 80 participants will be enrolled in this study. All will take part at MD Anderson.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-Video Double Lumen Tube (DLT) Group
Participants receive a non-video DLT for lung isolation before surgery. Once non-video DLT is in correct place, its final position before surgery checked with a fiberoptic bronchoscopy (FOB).
Non-Video Double Lumen Tube (DLT)
Participant receives non-video double lumen tube (DLT) placement before surgery.
Fiberoptic Bronchoscopy (FOB)
Fiberoptic bronchoscopy (FOB) performed to check placement of non-video DLT.
Video Double Lumen Tube (VDLT) Group
Participants receive a VDLT for lung isolation before surgery. Once VDLT is in correct place, its final position before surgery checked with the camera inside the tube.
Video Double Lumen Tube (VDLT)
Participant receives video double lumen tube (VDLT) placement before surgery.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non-Video Double Lumen Tube (DLT)
Participant receives non-video double lumen tube (DLT) placement before surgery.
Fiberoptic Bronchoscopy (FOB)
Fiberoptic bronchoscopy (FOB) performed to check placement of non-video DLT.
Video Double Lumen Tube (VDLT)
Participant receives video double lumen tube (VDLT) placement before surgery.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. 18 years or older
3. All patients to give written informed consent to participate
Exclusion Criteria
2. Patient requiring emergency operations
3. Patients with known difficult airways
4. Patients where other lung isolation devices may be warranted (tracheostomy, nasal intubation)
5. Patient requiring sizes not available in DLT or VDLT
6. Patients requiring a right sided VDLT or DLT
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
E.T. View Medical Ltd
OTHER
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jagtar S. Heir, DO
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Related Links
Access external resources that provide additional context or updates about the study.
University of Texas MD Anderson Cancer Center Website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2015-01551
Identifier Type: REGISTRY
Identifier Source: secondary_id
2014-0991
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.